142 related articles for article (PubMed ID: 32358805)
21. Primary Signet Ring Cell/Histiocytoid Carcinoma of the Eyelid: Clinicopathologic Analysis with Evaluation of the E-Cadherin/
Del Valle Estopinal M; Middleton LP; Esmaeli B; Patel KP; Nowroozizadeh S; Williams MD
Case Rep Pathol; 2021; 2021():6628150. PubMed ID: 34804623
[TBL] [Abstract][Full Text] [Related]
22. Genetic analysis of a case of Helicobacter pylori-uninfected intramucosal gastric cancer in a family with hereditary diffuse gastric cancer.
Funakoshi T; Miyamoto S; Kakiuchi N; Nikaido M; Setoyama T; Yokoyama A; Horimatsu T; Yamada A; Torishima M; Kosugi S; Yamada H; Sugimura H; Haga H; Sakai Y; Ogawa S; Seno H; Muto M; Chiba T
Gastric Cancer; 2019 Jul; 22(4):892-898. PubMed ID: 30542785
[TBL] [Abstract][Full Text] [Related]
23. Cutaneous metastasis as first clinical manifestation of signet ring cell gastric carcinoma.
Aneiros-Fernandez J; Husein-ElAhmed H; Arias-Santiago S; Escobar Gómez-Villalva F; Nicolae A; O'Valle Ravassa F; Aneiros-Cachaza J
Dermatol Online J; 2010 Mar; 16(3):9. PubMed ID: 20233566
[TBL] [Abstract][Full Text] [Related]
24. Metastatic lobular breast carcinoma mimicking primary signet ring adenocarcinoma in a patient with a suspected CDH1 mutation.
Mahmud N; Ford JM; Longacre TA; Parent R; Norton JA
J Clin Oncol; 2015 Feb; 33(4):e19-21. PubMed ID: 24590638
[No Abstract] [Full Text] [Related]
25. Effective diagnosis and surgical management of primary signet ring cell carcinoma of the eyelid.
Buset T; Vaudoisey L; De Saint Aubain N; Javadian R; Vanden Eynden X; Valyi Z; Dequanter D
J Surg Case Rep; 2023 Jul; 2023(7):rjad408. PubMed ID: 37485496
[TBL] [Abstract][Full Text] [Related]
26. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications.
Rogers WM; Dobo E; Norton JA; Van Dam J; Jeffrey RB; Huntsman DG; Kingham K; Chun N; Ford JM; Longacre TA
Am J Surg Pathol; 2008 Jun; 32(6):799-809. PubMed ID: 18391748
[TBL] [Abstract][Full Text] [Related]
27. Primary adenocarcinoma of the eyelid with signet ring cell and histiocytoid features.
Nazareth MR; Bogner P; Mansour N; Raghu PR; Mansour TN; Zeitouni NC
Dermatol Surg; 2012 Nov; 38(11):1882-5. PubMed ID: 22861355
[No Abstract] [Full Text] [Related]
28. Novel mechanism of a CDH1 splicing mutation in a Korean patient with signet ring cell carcinoma.
Kim S; Ki CS; Kim KM; Lee MG; Kim S; Bae JM; Kim JW
BMB Rep; 2011 Nov; 44(11):725-9. PubMed ID: 22118538
[TBL] [Abstract][Full Text] [Related]
29. Signet ring cell carcinoma of the eyelid - the monocle tumour.
Mortensen AL; Heegaard S; Clemmensen O; Prause JU
APMIS; 2008 Apr; 116(4):326-32. PubMed ID: 18397469
[TBL] [Abstract][Full Text] [Related]
30. Basal cell-signet-ring squamous cell carcinoma of the eyelid.
Proia AD; Selim MA; Reutter JC; Michon JJ
Arch Pathol Lab Med; 2006 Mar; 130(3):393-6. PubMed ID: 16519572
[TBL] [Abstract][Full Text] [Related]
31. Signet ring basal cell carcinoma. A case study emphasizing the differential diagnosis of neoplasms with signet ring cell formation.
Aroni K; Lazaris AC; Nikolaou I; Saetta A; Kavantzas N; Davaris PS
Pathol Res Pract; 2001; 197(12):853-6. PubMed ID: 11795835
[TBL] [Abstract][Full Text] [Related]
32. Outcomes of Endoscopic Surveillance in Individuals With Genetic Predisposition to Hereditary Diffuse Gastric Cancer.
Jacobs MF; Dust H; Koeppe E; Wong S; Mulholland M; Choi EY; Appelman H; Stoffel EM
Gastroenterology; 2019 Jul; 157(1):87-96. PubMed ID: 30935944
[TBL] [Abstract][Full Text] [Related]
33. Genetic Panel Test of Double Cancer of Signet-Ring Cell/Histiocytoid Carcinoma of the Eyelid and Papillary Thyroid Carcinoma: Case Report and Literature Review.
Kuroki M; Shibata H; Kuze B; Ohashi T; Kohyama K; Kato H; Kato H; Miyazaki T; Tomita H; Ogawa T
Cureus; 2022 May; 14(5):e25192. PubMed ID: 35747011
[TBL] [Abstract][Full Text] [Related]
34. Primary cutaneous histiocytoid carcinoma with distant metastasis.
Philips R; Langston L; Hwang H; Vandergriff T; Trynosky T; Berlingeri-Ramos AC
J Cutan Pathol; 2017 Apr; 44(4):376-380. PubMed ID: 28000303
[TBL] [Abstract][Full Text] [Related]
35. Pathology quiz case 2. Primary signet ring carcinoma of the eyelid.
Warrick JI; Lewis JS; Diaz JA
Arch Otolaryngol Head Neck Surg; 2010 Nov; 136(11):1146, 1148-9. PubMed ID: 21079175
[No Abstract] [Full Text] [Related]
36. Diagnosis and treatment of primary signet-ring cell carcinoma of the prostate.
Lilleby W; Axcrona K; Alfsen GC; Urnes T; Hole KH
Acta Oncol; 2007; 46(8):1195-7. PubMed ID: 17851841
[No Abstract] [Full Text] [Related]
37. Signet-ring cell carcinoma of the prostate effectively treated with maximal androgen blockade.
Akagashi K; Tanda H; Kato S; Ohnishi S; Nakajima H; Nanbu A; Nitta T; Koroku M
Int J Urol; 2003 Aug; 10(8):456-8. PubMed ID: 12887370
[TBL] [Abstract][Full Text] [Related]
38. Histopathologic Analysis of Signet-ring Cell Carcinoma In Situ in Patients With Hereditary Diffuse Gastric Cancer.
Tsugeno Y; Nakano K; Nakajima T; Namikawa K; Takamatsu M; Yamamoto N; Fujisaki J; Nunobe S; Kitagawa M; Takeuchi K; Kawachi H
Am J Surg Pathol; 2020 Sep; 44(9):1204-1212. PubMed ID: 32520759
[TBL] [Abstract][Full Text] [Related]
39. Signet ring cell carcinoma of the eccrine sweat glands in the eyelid.
Wollensak G; Witschel H; Böhm N
Ophthalmology; 1996 Nov; 103(11):1788-93. PubMed ID: 8942871
[TBL] [Abstract][Full Text] [Related]
40. [Primary signet ring cell carcinoma of urinary bladder. A case report].
Krichen Makni S; Ellouz S; Khabir A; Daoud J; Boudawara T
Cancer Radiother; 2005 Sep; 9(5):332-4. PubMed ID: 15949964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
